Fmoc-(R)-2-amino-2-methyl-4-pentenoic acid is a non-proteinogenic, unnatural amino acid derivative. Its structure features an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the amine, a chiral quaternary α-carbon bearing a methyl group, and an allyl side chain terminating in a reactive alkene. This specific configuration makes it a valuable chiral building block. This compound is primarily employed in solid-phase peptide synthesis (SPPS) as a protected amino acid monomer. The presence of the α,α-disubstituted (quaternary) center and the allyl group allows for the introduction of conformational constraints and unique chemical handles into synthetic peptides. These modifications are crucial in medicinal chemistry for developing peptide-based therapeutics, peptidomimetics, and chemical biology probes with enhanced metabolic stability, altered binding affinity, or sites for further functionalization (e.g., via thiol-ene "click" chemistry on the alkene). The Fmoc group is standard for temporary N-terminal protection in Fmoc/tBu SPPS strategies, allowing for mild base-mediated deprotection. Its main application is strictly within research and development for constructing novel peptide architectures, rather than as a bulk pharmaceutical intermediate or a material precursor.